Nanosphere is seeking FDA clearance for the assay, which would be used to provide early diagnosis of myocardial infarction and risk stratification for acute coronary syndromes.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.